Canary Capital is preparing to launch an ETF tracking Pepe’s price, despite the token trading 85% below its December 2024 all-time high.
Latest NewsRead More
You might also be interested in reading Takeda Pharmaceutical Non-GAAP EPS of ¥151.00, revenue of ¥1106.7B; reaffirms FY outlook.